Mumbai-headquartered Unichem Laboratories rose close to 11% in opening trade and is currently trading over 7%. This was on the back of the pharma major receiving the Establishment Inspection Report (EIR) for the post-marketing adverse drug experience. The inspection was conducted by the US Food and Drug Administration (USFDA) from June 25, 2018 to June 29, 2018..
To Get Free Trial
Missed call @ 8817002233
Call Us @ 8822117117
Mail Us = starindiamarket@gmail.com
Visit = http://www.starindiaresearch.com/freetrail.php
To Get Free Trial
Missed call @ 8817002233
Call Us @ 8822117117
Mail Us = starindiamarket@gmail.com
Visit = http://www.starindiaresearch.com/freetrail.php
No comments:
Post a Comment